BCKDK and hepatocellular carcinoma: Mechanistically, we found that APN might mediate the phosphorylation of serine at position 31 of BCKDK, then promote BCKDK binding and phosphorylating ERK1/2, thereby activating the ERK signaling pathway in HCC cells.